The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis
Open accessAbstract
Extensive research causally links amyloid-beta peptide (A beta) to Alzheimer's disease, although the pathologically relevant A beta conformation remains unclear. A beta spontaneously aggregates into the fibrils that deposit in senile plaques. However, recent in vivo and in vitro reports describe a potent biological activity for oligomeric assemblies of A beta. To consistently prepare in vitro oligomeric and fibrillar forms of A beta 1-42, a detailed knowledge of how solution parameters influence structure is required. This manuscript represents the first study using a single chemically and structurally homogeneous unaggregated starting material to demonstrate that the formation of oligomers, fibrils, and fibrillar aggregates is determined by time, concentration, temperature, pH, ionic strength, and A beta species. We recently reported that oligomers inhibit neuronal viability 10-fold more than fibrils and approximately 40-fold more than unaggregated peptide, with oligomeric A beta 1-42-induced neurotoxicity significant at 10 nm. In addition, we were able to differentiate by structure and neurotoxic activity wild-type A beta1-42 from isoforms containing familial mutations (Dahlgren, K. N., Manelli, A. M., Stine, W. B., Jr., Baker, L. K., Krafft, G. A., and LaDu, M. J. (2002) J. Biol. Chem. 277, 32046-32053). Understanding the biological role of specific A beta conformations may define the link between A beta and Alzheimer's disease, re-focusing therapeutic approaches by identifying the pernicious species of A beta ultimately responsible for the cognitive dysfunction that defines the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The 48 h total incubation leads to mature Aβ42 fibrils, as observed by TEM (Figure 10, panel a) while the Western blot shows the presence of higher order Aβ42 oligomers (Figure 10, lane a), likely due to an assembly-disassembly equilibrium that is established for mature Aβ fibrils.89–91”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [91]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition, the MOAB-2-based oA42 ELISA detects oligomeric but not monomeric A42 using synthetic preparations characterized previously by our laboratory (data not shown) (47,48).”
From APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease (2012) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Self-citationImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
Conway, K. A., Lee, S., Rochet, J., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,559
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526
Flagged first, then by citations
Research works printed but not linked: 3
- Hou, 2002, J. Biol. Chem., 26, 26
- DePace, 2002, Nat. Struct. Biol., 9, 389
- Fezoui, 2002, J. Biol. Chem., 30, 30
Cited by
Sorted by citations
Items 101–200 of 999
Lock, L. L., Reyes, C. D., Zhang, P., & Cui, H. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b00073 · Cited by 141
Fine structure study of Aβ 1–42 fibrillogenesis with atomic force microscopy
Arimon, M., Díez‐Pérez, I., Kogan, M. J., Durany, N., Giralt, E., Sanz, F., & Fernàndez‐Busquets, X. (2005) · The FASEB Journal · doi:10.1096/fj.04-3137fje · Cited by 141
Aβ Oligomers Induce Neuronal Cell Cycle Events in Alzheimer's Disease
Varvel, N. H., Bhaskar, K., Patil, A. R., Pimplikar, S. W., Herrup, K., & Lamb, B. T. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2441-08.2008 · Cited by 141
Bhaskar, K., Maphis, N. M., Xu, G., Varvel, N. H., Kokiko‐Cochran, O. N., Weick, J. P., Staugaitis, S. M., Cardona, A. E., Ransohoff, R. M., Herrup, K., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.007 · Cited by 141
The endocytic pathway in microglia during health, aging and Alzheimer’s disease
Solé-Domènech, S., Cruz, D. L., Capetillo-Zarate, E., & Maxfield, F. R. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.07.002 · Cited by 133
Wilkaniec, A., Gąssowska-Dobrowolska, M., Strawski, M., Adamczyk, A., & Czapski, G. A. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-017-1027-y · Cited by 133
RETRACTED: Cognitive effects of cell-derived and synthetically derived Aβ oligomers
Reed, M. N., Hofmeister, J. J., Jungbauer, L. M., Welzel, A. T., Yu, C., Sherman, M. A., Lesné, S., LaDu, M. J., Walsh, D. M., Ashe, K. H., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.11.007 · Cited by 135
Self-citationRetractedMaloney, M. T., Minamide, L. S., Kinley, A. W., Boyle, J. A., & Bamburg, J. R. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3711-05.2005 · Cited by 140
Eckert, A., Hauptmann, S., Scherping, I., Meinhardt, J., Rhein, V. F., Dröse, S., Brandt, U., Fändrich, M., Müller, W. E., & Götz, J. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0391-6 · Cited by 132
Simulations of nucleation and elongation of amyloid fibrils
Zhang, J., & Muthukumar, M. (2009) · The Journal of Chemical Physics · doi:10.1063/1.3050295 · Cited by 131
Itkin, A., Duprès, V., Dufrêne, Y. F., Bechinger, B., Ruysschaert, J., & Raussens, V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018250 · Cited by 131
Yang, T., Knowles, J. K., Lu, Q., Zhang, H., Arancio, O., Moore, L. A., Chang, T., Wang, Q., Andreasson, K. I., Rajadas, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003604 · Cited by 134
Zerbinatti, C. V., Wahrle, S. E., Kim, H., Cam, J. A., Bales, K., Paul, S. M., Holtzman, D. M., & Bu, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604436200 · Cited by 129
Miller, E. C., Teravskis, P. J., Dummer, B. W., Zhao, X., Huganir, R. L., & Liao, D. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12507 · Cited by 131
Wang, H., Liu, J., Zong, Y., Xu, Y., Deng, W., Zhu, H., Liu, Y. M., Ma, C., Huang, L. J., Zhang, L., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.023 · Cited by 130
Narayanan, S., & Reif, B. (2005) · Biochemistry · doi:10.1021/bi048264b · Cited by 128
Huang, M., Hu, M., Song, Q., Song, H., Huang, J., Gu, X., Wang, X., Chen, J., Kang, T., Feng, X., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b03124 · Cited by 127
Selection and characterization of Affibody ligands binding to Alzheimer amyloid β peptides
Grönwall, C., Jonsson, A., Lindström, S., Gunneriusson, E., Ståhl, S., & Herne, N. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.09.013 · Cited by 127
Ryan, T. M., Caine, J. M., Mertens, H. D. T., Kirby, N. M., Nigro, J., Breheney, K., Waddington, L. J., Streltsov, V. A., Curtain, C. C., Masters, C. L., et al. (2013) · PeerJ · doi:10.7717/peerj.73 · Cited by 133
Mechanism mediating oligomeric Aβ clearance by naïve primary microglia
Yang, C.-N., Shiao, Y.-J., Shie, F.-S., Guo, B.-S., Chen, P.-H., Cho, C.-Y., Chen, Y.-J., Huang, F.-L., & Tsay, H.-J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.005 · Cited by 117
Protein Interactions and Misfolding Analyzed by AFM Force Spectroscopy
McAllister, C., Karymov, M. A., Kawano, Y., Lushnikov, A. Y., Mikheikin, A., Uversky, V. N., & Lyubchenko, Y. L. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.10.012 · Cited by 129
Inflammatory mechanisms in neurodegeneration
Nichols, M. R., St‐Pierre, M., Wendeln, A., Makoni, N. J., Gouwens, L. K., Garrad, E. C., Sohrabi, M., Neher, J. J., Tremblay, M., & Combs, C. K. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14674 · Cited by 129
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Tian, C., Liu, G., Gao, L., Soltys, D., Pan, C., Stewart, T., Shi, M. Y., Xie, Z., Liu, N., Feng, T., et al. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0155-y · Cited by 127
Protective mechanisms by cystatin C in neurodegenerative diseases
Levy, E. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s170 · Cited by 122
The case for soluble Aβ oligomers as a drug target in Alzheimer's disease
Hefti, F. F., Goure, W. F., Jerecìć, J., Iverson, K. S., Walicke, P. A., & Krafft, G. A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.03.002 · Cited by 122
Self-citationJia, S., Zheng, L., Gao, Z., An, J., Wu, X., Li, X., Dai, X., Zheng, Q., & Sun, Y. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.11.011 · Cited by 121
Wang, Y., Xia, Z., Xu, J., Wang, Y., Hou, L., Qiu, Y. L., & Chen, H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.09.016 · Cited by 119
Photophysical study of Thioflavin T as fluorescence marker of amyloid fibrils
Freire, S., de Araujo, M. H., Al‐Soufi, W., & Novo, M. (2014) · Dyes and Pigments · doi:10.1016/j.dyepig.2014.05.004 · Cited by 119
Silvestri, R. (2008) · Medicinal Research Reviews · doi:10.1002/med.20132 · Cited by 118
β-Azidoalanine as an IR Probe: Application to Amyloid Aβ(16-22) Aggregation
Oh, K., Lee, J., Joo, C., Han, H., & Cho, M. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp801558k · Cited by 119
Impact of amyloid imaging on drug development in Alzheimer's disease
Mathis, C. A., Lopresti, B. J., & Klunk, W. E. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.06.015 · Cited by 121
Karr, J. W., & Szalai, V. A. (2008) · Biochemistry · doi:10.1021/bi702423h · Cited by 119
Self-Assembly of the Ionic Peptide EAK16: The Effect of Charge Distributions on Self-Assembly
Jun, S., Hong, Y., Imamura, H., Ha, B., Bechhoefer, J., & Chen, P. (2004) · Biophysical Journal · doi:10.1529/biophysj.103.038166 · Cited by 119
Cyclophilin D Deficiency Rescues Axonal Mitochondrial Transport in Alzheimer’s Neurons
Guo, L., Du, H., Yan, S., Wu, X., McKhann, G. M., Chen, J. X., & Yan, S. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054914 · Cited by 118
Zhang, Y., Rempel, D. L., Zhang, J., Sharma, A. K., Mirica, L. M., & Gross, M. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309175110 · Cited by 118
Protofibril Formation of Amyloid β-Protein at Low pH via a Non-cooperative Elongation Mechanism
Carrotta, R., Manno, M., Bulone, D., Martorana, V., & Biagio, P. L. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500052200 · Cited by 117
Fuentealba, R. A., Liu, Q., Zhang, J., Kanekiyo, T., Hu, X., Lee, J.-M., LaDu, M. J., & Bu, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011884 · Cited by 116
Self-citationAmyloid-β oligomers in cellular models of Alzheimer’s disease
Fontana, I. C., Zimmer, A. R., Rocha, A. S., Gosmann, G., Souza, D. O., Lourenco, M. V., Ferreira, S. T., & Zimmer, E. R. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15030 · Cited by 115
Cystatin C Protects Neuronal Cells from Amyloid-β-induced Toxicity
Tizón, B., Ribé, E. M., Mi, W., Troy, C. M., & Levy, E. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1291 · Cited by 115
Wesén, E. V., Jeffries, G. D. M., Dzebo, M. M., & Esbjörner, E. K. (2017) · Scientific Reports · doi:10.1038/s41598-017-02227-9 · Cited by 115
Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease
Madav, Y., Wairkar, S., & Prabhakar, B. R. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.01.004 · Cited by 122
Tickler, A. K., Smith, D. G., Ciccotosto, G. D., Tew, D. J., Curtain, C. C., Carrington, D., Masters, C. L., Bush, A. I., Cherny, R. A., Cappai, R., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414178200 · Cited by 115
Lindberg, D. J., Wesén, E. V., Björkeroth, J., Rocha, S., & Esbjörner, E. K. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.05.012 · Cited by 113
Pryor, N. E., Moss, M. A., & Hestekin, C. N. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13033038 · Cited by 113
Johansson, A., Berglind‐Dehlin, F., Karlsson, G., Edwards, K., Gellerfors, P., & Lannfelt, L. (2006) · FEBS Journal · doi:10.1111/j.1742-4658.2006.05263.x · Cited by 111
Drolle, E., Hane, F. T., Lee, B. Y., & Leonenko, Z. (2014) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.882354 · Cited by 120
Direct Observation of Nucleation and Growth in Amyloid Self-Assembly
Liang, Y., Lynn, D. G., & Berland, K. M. (2010) · Journal of the American Chemical Society · doi:10.1021/ja910964c · Cited by 112
Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice
Dewachter, I., Filipkowski, R. K., Priller, C., Ris, L., Neyton, J., Croes, S., Terwel, D., Gysemans, M., Devijver, H., Borghgraef, P., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.06.011 · Cited by 116
Rush, T., Hernández, J. M., Dollmeyer, M., Frandemiche, M., Borel, E., Boisseau, S., Jacquier‐Sarlin, M. R., & Buisson, A. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1409-18.2018 · Cited by 118
Cenini, G., Rüb, C., Bruderek, M., & Voos, W. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-05-0313 · Cited by 111
Liang, C., Zhu, H., Xu, Y., Huang, L. J., Ma, C., Deng, W., Liu, Y. M., & Qin, C. (2011) · Brain Research · doi:10.1016/j.brainres.2011.10.051 · Cited by 111
Shibuya, Y., Chang, C. C. Y., Huang, L.-H., Bryleva, E. Y., & Chang, T.-Y. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.2567-14.2014 · Cited by 108
Hashimoto, M., & Hossain, S. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.10r33fm · Cited by 113
Taniguchi, A., Sohma, Y., Kimura, M., Okada, T., Ikeda, K., Hayashi, Y., Kimura, T., Hirota, S., Matsuzaki, K., & Kiso, Y. (2005) · Journal of the American Chemical Society · doi:10.1021/ja057100v · Cited by 108
Klug, G. M., Lošić, D., Supundi, Subasinghe, S., Aguilar, M., Martin, L. L., & Small, D. H. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03815.x · Cited by 109
Synaptic transmission block by presynaptic injection of oligomeric amyloid beta
Moreno, H., Yu, E., Pigino, G. F., Hernandez, A. I., Kim, N., Moreira, J. E., Sugimori, M., & Llinás, R. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900944106 · Cited by 113
Adsorption of Amyloid β (1–40) Peptide at Phospholipid Monolayers
Maltseva, E., Kerth, A., Blume, A., Möhwald, H., & Brezesinski, G. (2005) · ChemBioChem · doi:10.1002/cbic.200500116 · Cited by 106
Choucair, A., Chakrapani, M., Chakravarthy, B., Katsaras, J., & Johnston, L. J. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.09.005 · Cited by 105
Prakash, P., Manchanda, P., Paouri, E., Bisht, K., Sharma, K., Rajpoot, J., Wendt, V., Hossain, A., Wijewardhane, P. R., Randolph, C. E., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.04.029 · Cited by 104
Bosson, A., Paumier, A., Boisseau, S., Jacquier‐Sarlin, M. R., Buisson, A., & Albrieux, M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0194-8 · Cited by 111
Lee, S., Fernández, E., & Good, T. A. (2007) · Protein Science · doi:10.1110/ps.062514807 · Cited by 104
Washington, P. M., Morffy, N., Parsadanian, M., Zapple, D. N., & Burns, M. P. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2013.3017 · Cited by 103
Gulisano, W., Melone, M., Ripoli, C., Tropea, M. R., Li Puma, D. D., Giunta, S., Cocco, S., Marcotulli, D., Origlia, N., Palmeri, A., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.0163-19.2019 · Cited by 100
Origin of metastable oligomers and their effects on amyloid fibril self-assembly
Hasecke, F., Miti, T., Perez, C., Barton, J., Schölzel, D., Gremer, L., Grüning, C. S. R., Matthews, G., Meisl, G., Knowles, T. P. J., et al. (2018) · Chemical Science · doi:10.1039/c8sc01479e · Cited by 103
Wang, Y., Wang, X., Lu, J.-J., Li, Q., Gao, C., Liu, X.-H., Sun, Y., Yang, M., Lim, Y. P., Evin, G. M., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2733-10.2011 · Cited by 99
Ryan, D. A., Narrow, W. C., Federoff, H. J., & Bowers, W. J. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.05.001 · Cited by 102
Davis, R. C., Marsden, I. T., Maloney, M. T., Minamide, L. S., Podlisny, M. B., Selkoe, D. J., & Bamburg, J. R. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-10 · Cited by 102
Wang, S., Liu, F., Dong, X., & Sun, Y. P. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp1001435 · Cited by 99
Chen, T., Wang, D., & Chen, S. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22057 · Cited by 99
A hydrogel biosensor for high selective and sensitive detection of amyloid-beta oligomers
Sun, L., Zhong, Y., Gui, J., Wang, X., Zhuang, X., & Weng, J. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s152163 · Cited by 100
Cerf, E., Gustot, A., Goormaghtigh, E., Ruysschaert, J.-M., & Raussens, V. (2011) · The FASEB Journal · doi:10.1096/fj.10-175976 · Cited by 92
Sequestration of Toxic Oligomers by HspB1 as a Cytoprotective Mechanism
Ojha, J., Masilamoni, G. J., Dunlap, D. D., Udoff, R. A., & Cashikar, A. G. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01187-10 · Cited by 99
ApoE and Aβ1–42 Interactions: Effects of Isoform and Conformation on Structure and Function
Manelli, A. M., Stine, W. B., Van Eldik, L. J., & LaDu, M. J. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:3:235 · Cited by 95
Self-citationEpilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link?
Costa, C., Parnetti, L., D'Amelio, M., Tozzi, A., Tantucci, M., Romigi, A., Siliquini, S., Cavallucci, V., Di Filippo, M., Mazzocchetti, P., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.08.025 · Cited by 94
Stable, Metastable, and Kinetically Trapped Amyloid Aggregate Phases
Miti, T., Mulaj, M., Schmit, J. D., & Muschol, M. (2014) · Biomacromolecules · doi:10.1021/bm501521r · Cited by 93
Fu, W., Ruangkittisakul, A., MacTavish, D., Shi, J., Ballanyi, K., & Jhamandas, J. H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.331181 · Cited by 95
He, Y., Cui, J., Lee, J. C., Ding, S., Chalimoniuk, M., Simonyi, Á., Sun, A. Y., Gu, Z., Weisman, G. A., Wood, W. G., et al. (2011) · ASN NEURO · doi:10.1042/an20100025 · Cited by 95
The interaction of beta-amyloid protein with cellular membranes stimulates its own production
Peters, I., Igbavboa, U., Schuett, T., Haidari, S., Hartig, U., Rossello, X. S., Böttner, S., Copanaki, E., Deller, T., Kögel, D., et al. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.01.012 · Cited by 91
Lee, L., Sakurai, M., Matsuzaki, S., Arancio, O., & Fraser, P. E. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8257-7 · Cited by 94
Shaw, C. P., Middleton, D. A., Volk, M., & Lévy, R. (2012) · ACS Nano · doi:10.1021/nn204214x · Cited by 90
Sohma, Y., Hayashi, Y., Kimura, M., Chiyomori, Y., Taniguchi, A., Sasaki, M., Kimura, T., & Kiso, Y. (2005) · Journal of Peptide Science · doi:10.1002/psc.649 · Cited by 90
Kuszczyk, M. A., Sanchez, S., Pankiewicz, J., Kim, J., Duszczyk, M., Guridi, M., Asuni, A. A., Sullivan, P. M., Holtzman, D. M., & Sadowski, M. J. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.01.034 · Cited by 89
“Buildup of Ab is a result of a disequilibrium between the rate of its generation and the rate of its brain clearance(3) and is driven by inherently low solubility and natural propensity of Ab to self-assemble into oligomers and fibrils.(4) Ab fibrils, which are deposited as senile plaques and cerebral amyloid angiopat…”
BackgroundN-truncated amyloid-β oligomers induce learning impairment and neuronal apoptosis
Youssef, I., Florent‐Béchard, S., Malaplate, C., Koziel, V., Bihain, B. E., Olivier, J. L., Leininger‐Muller, B., Kriem, B., Oster, T., & Pillot, T. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.005 · Cited by 97
pH-Dependent Amyloid and Protofibril Formation by the ABri Peptide of Familial British Dementia
Srinivasan, R., Jones, E. M., Liu, K., Ghiso, J. A., Marchant, R. E., & Zagorski, M. G. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.09.001 · Cited by 89
Rahimi, F., Shanmugam, A., & Bitan, G. (2008) · Current Alzheimer Research · doi:10.2174/156720508784533358 · Cited by 88
Aβ1-42 monomers or oligomers have different effects on autophagy and apoptosis
Guglielmotto, M., Monteleone, D., Piras, A., Valsecchi, V., Tropiano, M., Ariano, S., Fornaro, M., Vercelli, A., Puyal, J., Arancio, O., et al. (2014) · Autophagy · doi:10.4161/auto.30001 · Cited by 90
Faller, P., Hureau, C., Dorlet, P., Hellwig, P., Coppel, Y., Collin, F., & Aliès, B. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.015 · Cited by 86
Single-Molecule Atomic Force Microscopy Force Spectroscopy Study of Aβ-40 Interactions
Kim, B., Palermo, N. Y., Lovas, S., Zaikova, T. O., Keana, J. F. W., & Lyubchenko, Y. L. (2011) · Biochemistry · doi:10.1021/bi200147a · Cited by 86
Amino Acid Position-specific Contributions to Amyloid β-Protein Oligomerization
Maji, S. K., Loo, R. R. O., Inayathullah, M., Spring, S. M., Vollers, S. S., Condron, M. M., Bitan, G., Loo, J. A., & Teplow, D. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.038133 · Cited by 86
de Dios, C., Abadin, X., Roca-Agujetas, V., Jimenez-Martinez, M., Morales, A., Trullas, R., Mari, M., & Colell, A. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00343-3 · Cited by 85
Vilalta, A., Zhou, Y., Sevalle, J., Griffin, J. K., Satoh, K., Allendorf, D. H., De, S., Puigdellívol, M., Bruzas, A., Burguillos, M. A., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100631 · Cited by 77
Curcuminoid Binds to Amyloid-β1-42 Oligomer and Fibril
Yanagisawa, D., Taguchi, H., Yamamoto, A., Shirai, N., Hirao, K., & Tooyama, I. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-102100 · Cited by 85
Capping of Aβ42 Oligomers by Small Molecule Inhibitors
Fu, Z., Aucoin, D., Ahmed, M., Ziliox, M., Nostrand, W. E. V., & Smith, S. O. (2014) · Biochemistry · doi:10.1021/bi500910b · Cited by 87
Development of O ‐acyl isopeptide method
Sohma, Y., Yoshiya, T., Taniguchi, A., Kimura, T., Hayashi, Y., & Kiso, Y. (2007) · Biopolymers · doi:10.1002/bip.20683 · Cited by 86
Amyloid-like Conformation and Interaction for the Self-Assembly in Barnacle Underwater Cement
Nakano, M., & Kamino, K. (2014) · Biochemistry · doi:10.1021/bi500965f · Cited by 84
Roselli, F., Hutzler, P., Wegerich, Y., Livrea, P., & Almeida, O. F. X. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006011 · Cited by 88
Arai, T., Sasaki, D., Araya, T., Sato, T., Sohma, Y., & Kanai, M. (2014) · ChemBioChem · doi:10.1002/cbic.201402430 · Cited by 83
Fossati, S., Cam, J. A., Meyerson, J. L., Mezhericher, E., Romero, I. A., Couraud, P., Weksler, B. B., Ghiso, J. A., & Rostagno, A. A. (2009) · The FASEB Journal · doi:10.1096/fj.09-139584 · Cited by 86
Modes of Aβ toxicity in Alzheimer’s disease
Götz, J., Eckert, A., Matamales, M., Ittner, L. M., & Liu, X. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0750-2 · Cited by 87
Autoantibody-catalyzed Hydrolysis of Amyloid β Peptide
Taguchi, H., Planque, S. A., Nishiyama, Y., Symersky, J., Boivin, S., Szabo, P., Friedland, R. P., Ramsland, P. A., Edmundson, A. B., Weksler, M. E., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707983200 · Cited by 81
Metadata
- Authors
- Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J.
- Affiliations
- Northwestern University (US)
- Corresponding author
- LaDu, Mary Jo
- ORCID
- LaDu, Mary Jo
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 278
- Issue
- 13
- Pages
- 11612-11622
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2133631618
- Cited by
- 1,015
- References
- 74
- Citations by year
- 2026: 40 · 2025: 39 · 2024: 37 · 2023: 39 · 2022: 34 · 2021: 49 · 2020: 37 · 2019: 40 · 2018: 33 · 2017: 46 · 2016: 49 · 2015: 42 · 2014: 60 · 2013: 52 · 2012: 69
- FWCI
- 19.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- Northwestern University
- National Institutes of Health (1p01ag015501-01, 5r01ag013496-05)
- National Institute on Aging (R01AG019121, AG-15501, AG 19121, AG13496)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, amyloid-beta 42, oligomerization, fibril formation, Alzheimer's disease, neurotoxicity, peptide aggregation, solution conditions, familial Alzheimer's disease mutations, amyloid plaques, peptide conformation
- MeSH terms
- Biopolymers, Circular Dichroism, Electrophoresis, Polyacrylamide Gel, Peptide Fragments, Solubility, Blotting, Western, Amyloid beta-Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review